ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Artificial intelligence in cancer research and precision medicine: Applications, limitations and priorities to drive transformation in the delivery of equitable and unbiased care

Corti, Chiara*; Cobanaj, Marisa; Dee, Edward C.; Criscitiello, Carmen; Tolaney, Sara M.; Celi, Leo A.; Curigliano, Giuseppe
Cancer Treatment Reviews2023-1DOI: 10.1016/j.ctrv.2022.102498
26被引10阅读
引用收藏
分享

摘要

Artificial intelligence (AI) has experienced explosive growth in oncology and related specialties in recent years. The improved expertise in data capture, the increased capacity for data aggregation and analytic power, along with decreasing costs of genome sequencing and related biologic "omics", set the foundation and need for novel tools that can meaningfully process these data from multiple sources and of varying types. These advances provide value across biomedical discovery, diagnosis, prognosis, treatment, and prevention, in a multimodal fashion. However, while big data and AI tools have already revolutionized many fields, medicine has partially lagged due to its complexity and multi-dimensionality, leading to technical challenges in developing and vali-dating solutions that generalize to diverse populations. Indeed, inner biases and miseducation of algorithms, in view of their implementation in daily clinical practice, are increasingly relevant concerns; critically, it is possible for AI to mirror the unconscious biases of the humans who generated these algorithms. Therefore, to avoid worsening existing health disparities, it is critical to employ a thoughtful, transparent, and inclusive approach that involves addressing bias in algorithm design and implementation along the cancer care continuum.In this review, a broad landscape of major applications of AI in cancer care is provided, with a focus on cancer research and precision medicine. Major challenges posed by the implementation of AI in the clinical setting will be discussed. Potentially feasible solutions for mitigating bias are provided, in the light of promoting cancer health equity.

学科与关键词

关键词
Artificial intelligenceBiasDecision supportOutcome predictionEquityPrecision medicine
相关
加载中…
  • Towards equitable AI in oncology
    Viswanathan, Vidya Sankar; Parmar, Vani; Madabhushi, Anant*Nature Reviews. Clinical Oncology, 2024, 21(8): 628-637.被引 3
  • Artificial Intelligence in Cancer Research and Precision Medicine
    Bhinder, Bhavneet; Gilvary, Coryandar; Madhukar, Neel S.; Elemento, Olivier*Cancer Discovery, 2021, 11(4): 900-915.被引 254
  • Translating cancer genomics into precision medicine with artificial intelligence: applications, challenges and future perspectives
    Xu, Jia*; Yang, Pengwei; Xue, Shang; Sharma, Bhuvan; Sanchez-Martin, Marta; Wang, Fang; Beaty, Kirk A.; Dehan, Elinor; Parikh, BaijuHuman Genetics, 2019, 138(2): 109-124.被引 121
查看全部 →

发表信息

论文状态
公开发表
期刊
Cancer Treatment Reviews
发表日期
2023-01
卷期
第 112 卷
页码
102498
DOI
10.1016/j.ctrv.2022.102498
语言
ENGLISH
成果收录
SCIE

作者

  • C

    Corti, Chiara (通讯) (第一作者)

  • C

    Cobanaj, Marisa

查看全部 7 位作者收起作者
  • D

    Dee, Edward C.

  • C

    Criscitiello, Carmen

  • T

    Tolaney, Sara M.

  • C

    Celi, Leo A.

  • C

    Curigliano, Giuseppe

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417